Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment® ...

Wright Medical Group, Inc. today announced it has reached an agreement with the Office of Device Evaluation of the U.S. Food and Drug Administration under which ODE will accept a further amendment to the Pre-Market Approval application for Augment® Bone Graft in lieu of proceeding with the Dispute Resolution Panel that was scheduled for the week of May 19, 2014.



from Content Keyword RSS http://ift.tt/1lPFrTh

via IFTTT